Global prospective, multi-center, single-arm study assessing the safety and effectiveness of Shockwave peripheral IVL in treating long, calcified BTK lesions.
-
-
The first prospective, female-only study of coronary interventions in complex calcific disease, in collaboration with female leaders. -
Individual patient data pooled from DISRUPT CAD I-IV to see Shockwave IVL outcomes, fracture analysis and stent expansion predictors.
-
The largest prospective real-world evidence for the treatment of complex, heavily calcified peripheral arterial disease (PAD).
-
Shockwave coronary study demonstrating the safety and effectiveness of Shockwave IVL within a Japanese patient population.
-
Largest and most rigorous Shockwave study showcasing safety, effectiveness and ease of use of Shockwave coronary IVL.
-
The largest systematic assessment of Shockwave coronary Intravascular Lithotripsy (IVL) to date based on individual patient data from DISRUPT CAD I–IV.
-
The largest-ever randomized clinical study of Shockwave peripheral IVL treatment in severely calcified peripheral lesions, out to 24 months.
-
European post-market study confirming DISRUPT CAD I results and showing strong safety and procedural success with Shockwave coronary IVL.
Showing 1 to 9 of 13 results